Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
11.41
+5.96 (109.36%)
At close: Aug 19, 2026, 4:00 PM EDT
9.70
-1.71 (-14.96%)
After-hours: Aug 19, 2026, 7:59 PM EDT
Tenon Medical Revenue
Tenon Medical had revenue of $1.28M in the quarter ending June 30, 2026, with 126.77% growth. This brings the company's revenue in the last twelve months to $5.31M, up 80.25% year-over-year. In the year 2025, Tenon Medical had annual revenue of $3.94M with 20.35% growth.
Revenue (ttm)
$5.31M
Revenue Growth
+80.25%
P/S Ratio
1.07
Revenue / Employee
$204,308
Employees
26
Market Cap
5.66M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.94M | 667.00K | 20.35% |
| Dec 31, 2024 | 3.28M | 349.00K | 11.92% |
| Dec 31, 2023 | 2.93M | 2.24M | 323.73% |
| Dec 31, 2022 | 691.00K | 531.00K | 331.88% |
| Dec 31, 2021 | 160.00K | 116.18K | 265.13% |
| Dec 31, 2020 | 43.82K | -9.82K | -18.31% |
| Dec 31, 2019 | 53.64K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 43.79M |
| WORK Medical Technology Group LTD | 10.72M |
| Picard Medical | 5.47M |
| Biomerica | 4.33M |
| Intelligent Bio Solutions | 4.22M |
| VolitionRx | 2.46M |
| Co-Diagnostics | 721.39K |
| Nexalin Technology | 217.16K |
TNON News
- 17 hours ago - Tenon Medical Inc trading resumes - TheFly
- 17 hours ago - Tenon Medical Inc trading halted, volatility trading pause - TheFly
- 2 days ago - Tenon Medical Registration statement: Registration filing - Filings
- 2 days ago - Tenon Medical files $100M mixed securities shelf - TheFly
- 6 days ago - Tenon Medical Earnings Call Transcript: Q2 2026 - Transcripts
- 6 days ago - Tenon Medical Earnings release: Q2 2026 - Filings
- 6 days ago - Tenon Medical Quarterly report: Q2 2026 - Filings
- 6 days ago - Tenon Medical Reports Second Quarter 2026 Financial Results - Accesswire